Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 5, 2012, Pages 479-483

  Na, Kyung Sun ^a   Kim, Man Soo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC SERUM EYE DROPS; ARTIFICIAL TEAR; EYE DROPS; UNCLASSIFIED DRUG;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLURRED VISION; BONE MARROW TRANSPLANTATION; CELL DENSITY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRY EYE; FEMALE; GOBLET CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPRESSION CYTOLOGY; LACRIMAL FLUID; MALE; OCULAR SURFACE DISEASE; OSMOLARITY; PHOTOPHOBIA; PROSPECTIVE STUDY; SCHIRMER TEST; SEROLOGY; SLIT LAMP; UNSPECIFIED SIDE EFFECT;

ADULT; CHRONIC DISEASE; DRY EYE SYNDROMES; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; SEROLOGIC TESTS; SERUM; TEARS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867032797     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0002     Document Type: Article

References (32)

1. Balaram, M., Rashid, S., and Dana, R. Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul. Surf. 3:203-211, 2005.
2. Ferrara, J.L., et al. Graft-versus-host disease. Lancet. 373: 1550-1561, 2009.
3. Riemens, A., et al. Current insights into ocular graft-versushost disease. Curr. Opin. Ophthalmol. 21:485-494, 2010.
4. Westeneng, A.C., et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea. 29:758-763, 2010.
5. Saito, T., et al. Ocular manifestation of acute graft-versushost disease after allogeneic peripheral blood stem cell transplantation. Int. J. Hematol. 75:332-334, 2002.
6. Ogawa, Y., and Kuwana, M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea. 22:S19-S27.
7. Khanal, S., and Tomlinson, A. Tear physiology in dry eye associated with chronic GVHD. Bone Marrow Transplant. 47:115-119, 2012.
8. Dogru, M., and Tsubota, K. Pharmacotherapy of dry eye. Expert Opin. Pharmacother. 12:325-334, 2011.
9. Geerling, G., et al. Autologous serum and alternative blood products for the treatment of ocular surface disorders. Ophthalmologe. 105:623-631, 2008.
10. Geerling, G., Maclennan, S., and Hartwig, D. Autologous serum eye drops for ocular surface disorders. Br. J. Ophthalmol. 88:1467-1474, 2004.
11. O'Brien, P.D., and Collum, L.M. Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep. 4:314-319, 2004.
12. Samarkos, M., and Moutsopoulos, H.M. Recent advances in the management of ocular complications of Sjö gren's syndrome. Curr. Allergy Asthma Rep. 5:327-332, 2005.
13. Fox, R.I., et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 27:459-461, 1984.
14. Chiang, C.C., et al. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graftversus-host disease. Cornea. 26:861-863, 2007.
15. Kojima, T., et al. Autologous serum eye drops for the treatment of dry eye diseases. Cornea. 27 Suppl 1:S25-S30, 2008.
16. Rocha, E.M., et al. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant. 25:1101-1103, 2000.
17. Ogawa, Y., et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versushost disease. Bone Marrow Transplant. 31:579-583, 2003.
18. Yoon, K.C., et al. Therapeutic effect of umbilical cord serum eye drops for the treatment of dry eye associated with graftversus-host disease. Bone Marrow Transplant. 39:231-235, 2007.
19. Tseng, S.C. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 92:728-733, 1985.
20. Vigorito, A.C., et al. National Institutes of Health. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood. 114:702-708, 2009.
21. Shulman, H.M., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am. J. Med. 69:204-217, 1980.
22. Jack, M.K., and Hicks, J.D. Ocular complications in highdose chemoradiotherapy and marrow transplantation. Ann. Ophthalmol. 13:709-711, 1981.
23. Russo, P.A., Bouchard, C.S., and Galasso, J.M. Extendedwear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Eye Contact Lens. 33:144-147, 2007.
24. Hassan, A.S., et al. Lacrimal gland involvement in graftversus-host disease: a murine model. Invest. Ophthalmol. Vis. Sci. 46:2692-2697, 2005.
25. Ogawa, Y., et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest. Ophthalmol. Vis. Sci. 42:111-119, 2001.
26. Robinson, M.R., et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versushost disease. Bone Marrow Transplant. 33:1031-1035, 2004.
27. Wang, Y., et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant. 41:293-302, 2008.
28. Kurt, R.A., et al. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease. Ann. Ophthalmol. (Skokie). 41:166-169, 2009.
29. Lelli, G.J., Jr., Musch, D.C., et al. Ophthalmic cyclosporine use in ocular GVHD. Cornea. 25:635-638, 2006.
30. Tam, P.M., et al. Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD. Bone Marrow Transplant. 45:957-958, 2010.
31. Ogawa, Y., et al. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. Bone Marrow Transplant. 45:565-569, 2010.
32. Tananuvat, N., et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 20:802-806, 2001.